Exercise Pills: At the Starting Line

Trends in Pharmacological Sciences

Volumn 36, Issue 12, 2015, Pages 906-917

  Li, Shunchang ^a,b   Laher, Ismail ^c  

^a BEIJING SPORT UNIVERSITY   (China)

^b Xichang University   (China)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; DRUG; EPICATECHIN; EXERCISE PILL; GSK 4716; IRISIN; METFORMIN; RESVERATROL; SR 9009; UNCLASSIFIED DRUG; [2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; ACETYLCARNITINE; BIOMIMETIC MATERIAL; CATECHIN; FIBRONECTIN; FNDC5 PROTEIN, HUMAN; PYRROLIDINE DERIVATIVE; SR9009; STILBENE DERIVATIVE; THIAZOLE DERIVATIVE; THIOPHENE DERIVATIVE;

ANGIOGENESIS; BIOGENESIS; DRUG MECHANISM; EPIGENETICS; EXERCISE; HUMAN; MITOCHONDRION; MOLECULAR MECHANICS; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; PHYSICAL INACTIVITY; PRIORITY JOURNAL; REVIEW; SEDENTARY LIFESTYLE; VASCULARIZATION; ANIMAL; MOLECULARLY TARGETED THERAPY; PHYSIOLOGY;

ACETYLCARNITINE; ANIMALS; BIOMIMETIC MATERIALS; CATECHIN; EXERCISE; FIBRONECTINS; HUMANS; MOLECULAR TARGETED THERAPY; PYRROLIDINES; STILBENES; THIAZOLES; THIOPHENES;

EID: 84949036722     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2015.08.014     Document Type: Review

References (111)

1. L.H. Mellett, and G. Bousquet Cardiology patient page. Heart-healthy exercise Circulation 127 2013 e571 e572
2. F.W. Booth, and et al. Reduced physical activity and risk of chronic disease: the biology behind the consequences Eur. J. Appl. Physiol. 102 2008 381 390
3. M.V. Chakravarthy, and F.W. Booth Eating, exercise, and 'thrifty' genotypes: connecting the dots toward an evolutionary understanding of modern chronic diseases J. Appl. Physiol. 96 2004 3 10
4. H. Wallberg-Henriksson, and J.R. Zierath Metabolism. Exercise remodels subcutaneous fat tissue and improves metabolism Nat. Rev. Endocrinol 11 2015 198 200
5. R. Ross, and et al. Effects of exercise amount and intensity on abdominal obesity and glucose tolerance in obese adults: a randomized trial Ann. Intern. Med. 162 2015 325 334
6. J.P. Ahtiainen, and et al. Exercise type and volume alter signaling pathways regulating skeletal muscle glucose uptake and protein synthesis Eur. J. Appl. Physiol. 115 2015 1835 1845
7. J. Vina, and et al. Exercise acts as a drug; the pharmacological benefits of exercise Br. J. Pharmacol. 167 2012 1 12
8. T. Eckard, and et al. Home exercise program compliance of service members in the deployed environment: an observational cohort study Mil. Med. 180 2015 186 191
9. L. Islam, and D. Svikis Behavioral incentives to promote exercise compliance in cocaine-dependent women Drug Alcohol Depend. 146 2015 e146
10. V.M. Conraads, and et al. Adherence of heart failure patients to exercise: barriers and possible solutions: a position statement of the Study G-roup on Exercise Training in Heart Failure of the Heart Failure Association of the European Society of Cardiology Eur. J. Heart Fail. 14 2012 451 458
11. E.M. Sluijs, and E.B. Kuijper Problems patients encounter in educating patients Nederl. Tijdrch. Fysiother. 100 1990 128 132 (in Dutch); related follow-up paper: Sluijs, E.M. et al. (1993) Correlates of exercise compliance in physical therapy. Phys. Ther. 73, 771-786
12. M.H. van der Wal, and et al. Compliance in heart failure patients: the importance of knowledge and beliefs Eur. Heart J. 27 2006 434 440
13. M. Lagouge, and et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α Cell 127 2006 1109 1122
14. V.A. Narkar, and et al. AMPK and PPARδ agonists are exercise mimetics Cell 134 2008 405 415
15. S.M. Rangwala, and et al. Estrogen-related receptor gamma is a key regulator of muscle mitochondrial activity and oxidative capacity J. Biol. Chem. 285 2010 22619 22629
16. L. Nogueira, and et al. (-)-Epicatechin enhances fatigue resistance and oxidative capacity in mouse muscle J. Physiol. 589 2011 4615 4631
17. P. Bostrom, and et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis Nature 481 2012 463 468
18. E. Woldt, and et al. Rev-erb-α modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy Nat. Med. 19 2013 1039 1046
19. C. Lee, and et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance Cell Metab. 21 2015 443 454
20. J. Himms-Hagen Exercise in a pill: feasibility of energy expenditure targets Curr. Drug Targets CNS Neurol. Disord. 3 2004 389 409
21. R.L. Sabina, and et al. The enzymatic synthesis of 5-amino-4-imidazolecarboxamide riboside triphosphate (ZTP) Science 223 1984 1193 1195
22. M. Galinanes, and et al. Sustained protection by acadesine against ischemia- and reperfusion-induced injury studies in the transplanted rat heart Circulation 86 1992 589 597
23. M. Suwa, and et al. Effects of chronic AICAR treatment on fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles J. Appl. Physiol. 95 2003 960 968
24. W.W. Winder, and et al. Role of AMP-activated protein kinase in the molecular adaptation to endurance exercise Med. Sci. Sports Exerc. 38 2006 1945 1949
25. D.G. Hardie, and et al. AMPK: a nutrient and energy sensor that maintains energy homeostasis Nat. Rev. Mol. Cell Biol. 13 2012 251 262
26. X.J. Xu, and et al. AMP-activated protein kinase (AMPK): does this master regulator of cellular energy state distinguish insulin sensitive from insulin resistant obesity? Curr. Obes. Rep. 3 2014 248 255
27. J. Li, and et al. Modulation of an RNA-binding protein by abscisic-acid-activated protein kinase Nature 418 2002 793 797
28. M.E. Osler, and J.R. Zierath Adenosine 5′-monophosphate-activated protein kinase regulation of fatty acid oxidation in skeletal muscle Endocrinology 149 2008 935 941
29. H. Liang, and W.F. Ward PGC-1α: a key regulator of energy metabolism Adv. Physiol. Educ. 30 2006 145 151
30. D.J. Asby, and et al. AMPK activation via modulation of de novo purine biosynthesis with an inhibitor of ATIC homodimerization Chem. Biol. 22 2015 838 848
31. G. Zhou, and et al. Role of AMP-activated protein kinase in mechanism of metformin action J. Clin. Invest. 108 2001 1167 1174
32. B. Braun, and et al. Impact of metformin on peak aerobic capacity Appl. Physiol. Nutr. Metab. 33 2008 61 67
33. A.K. Wong, and et al. The effect of metformin on insulin resistance and exercise parameters in patients with heart failure Eur. J. Heart Fail. 14 2012 1303 1310
34. C. Cadeddu, and et al. Effects of Metformin Treatment on Myocardial and Endothelial Function in Insulin Resistance Patients: a Metabolomic Study J. Diabetes Metab. 4 2013 279
35. C. Cadeddu, and et al. Cardiopulmonary and endothelial effects of metformin treatment in an insulin resistant population Int. J. Cardiol. 158 2012 302 304
36. S.K. Malin, and et al. Independent and combined effects of exercise training and metformin on insulin sensitivity in individuals with prediabetes Diabetes Care 35 2012 131 136
37. X.M. Leverve, and et al. Mitochondrial metabolism and type-2 diabetes: a specific target of metformin Diabetes Metab. 29 2003 6S88-6S94
38. M.R. Owen, and et al. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain Biochem. J. 348 2000 607 614
39. B. Guigas, and et al. Metformin inhibits mitochondrial permeability transition and cell death: a pharmacological in vitro study Biochem. J. 382 2004 877 884
40. C. Batandier, and et al. The ROS production induced by a reverse-electron flux at respiratory-chain complex 1 is hampered by metformin J. Bioenerg. Biomembr. 38 2006 33 42
41. W.R. Oliver, and et al. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport Proc. Natl. Acad. Sci. U.S.A. 98 2001 5306 5311
42. D.L. Sprecher, and et al. Triglyceride: high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor delta agonist Arterioscler. Thromb. Vasc. Biol. 27 2007 359 365
43. U. Dressel, and et al. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells Mol. Endocrinol. 17 2003 2477 2493
44. G.D. Barish, and et al. PPAR delta: a dagger in the heart of the metabolic syndrome J. Clin. Invest. 116 2006 590 597
45. S. Luquet, and et al. Peroxisome proliferator-activated receptor δ controls muscle development and oxidative capability FASEB J. 17 2003 2299 2301
46. Y.X. Wang, and et al. Regulation of muscle fiber type and running endurance by PPARδ PLoS Biol. 2 2004 e294
47. M. Schuler, and et al. PGC1α expression is controlled in skeletal muscles by PPARβ, whose ablation results in fiber type switching, obesity, and type 2 diabetes Cell Metab. 4 2006 407 414
48. R. Bassel-Duby, and et al. Signaling pathways in skeletal muscle remodeling Annu. Rev. Biochem. 75 2006 19 37
49. B. Vitošević, and et al. Role of PPAR-δ in determination of muscle fiber type in response to exercise Acta Med. Median. 50 2011 57 62
50. W.J. Zuercher, and et al. Identification and structure-activity relationship of phenolic acyl hydrazones as selective agonists for the estrogen-related orphan nuclear receptors ERRβ and ERRγ J. Med. Chem. 48 2005 3107 3109
51. V.A. Narkar, and et al. Exercise and PGC-1α-independent synchronization of type I muscle metabolism and vasculature by ERRγ Cell Metab. 13 2011 283 293
52. L.A. Solt, and et al. Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists Nature 485 2012 62 68
53. M.A. Lazar, and et al. Gene expression from the c-erbA Rev-ErbA genomic locus J. Biol. Chem. 265 1990 12859 12863
54. H. Duez, and B. Staels Nuclear receptors linking circadian rhythms and cardiometabolic control Arterioscler. Thromb. Vasc. Biol. 30 2010 1529 1534
55. A. Bugge, and et al. Rev-erbα and Rev-erbβ coordinately protect the circadian clock and normal metabolic function Genes Dev. 26 2012 657 667
56. H. Cho, and et al. Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β Nature 485 2012 123 127
57. K. Zarse, and M. Ristow A mitochondrially encoded hormone ameliorates obesity and insulin resistance Cell Metab. 21 2015 355 356
58. F. Sanchis-Gomar, and et al. Irisin: a new potential hormonal target for the treatment of obesity and type 2 diabetes J. Diabetes 4 2012 196
59. E. Albrecht, and et al. Irisin - a myth rather than an exercise-inducible myokine Sci. Rep. 5 2015 8889
60. H.P. Erickson Irisin and FNDC5 in retrospect: an exercise hormone or a transmembrane receptor? Adipocyte 2 2013 289 293
61. J.A. Timmons, and et al. Is irisin a human exercise gene? Nature 488 2012 E9 E10 discussion, E10-E11
62. S. Raschke, and et al. Evidence against a beneficial effect of irisin in humans PLoS ONE 8 2013 e73680
63. A.D. Anastasilakis, and et al. Circulating irisin in healthy, young individuals: day-night rhythm, effects of food intake and exercise, and associations with gender, physical activity, diet, and body composition J. Clin. Endocrinol. Metab. 99 2014 3247 3255
64. J.Y. Huh, and et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise Metabolism 61 2012 1725 1738
65. R.R. Kraemer, and et al. A transient elevated irisin blood concentration in response to prolonged, moderate aerobic exercise in young men and women Horm. Metab. Res. 46 2014 150 154
66. Y. Tsuchiya, and et al. High-intensity exercise causes greater irisin response compared Tohoku J. Exp. Med. 232 2014 135 140
67. S. Ellefsen, and et al. Irisin and FNDC5: effects of 12-week strength training, and relations to muscle phenotype and body mass composition in untrained women Eur. J. Appl. Physiol. 114 2014 1875 1888
68. M. Alvehus, and et al. Metabolic adaptations in skeletal muscle, adipose tissue, and whole-body oxidative capacity in response to resistance training Eur. J. Appl. Physiol. 114 2014 1463 1471
69. T. Hofmann, and et al. Irisin levels are not affected by physical activity in patients with anorexia nervosa Front. Endocrinol. 4 2014 202
70. F. Norheim, and et al. The effects of acute and chronic exercise on PGC-1α, irisin and browning of subcutaneous adipose tissue in humans FEBS J. 281 2014 739 749
71. T. Kurdiova, and et al. Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies J. Physiol. 592 2014 1091 1107
72. A. Hecksteden, and et al. Irisin and exercise training in humans - results from a randomized controlled training trial BMC Med. 11 2013 235
73. S. Pekkala, and et al. Are skeletal muscle FNDC5 gene expression and irisin release regulated by exercise and related to health? J. Physiol. 591 2013 5393 5400
74. P.J. Atherton, and B.E. Phillips Greek goddess or Greek myth: the effects of exercise on irisin/FNDC5 in humans J. Physiol. 591 2013 5267 5268
75. M.P. Jedrychowski, and et al. Detection and quantitation of circulating human irisin by tandem mass spectrometry Cell Metab. 2015 10.1016/j.cmet.2015.08.001 Published online August 13, 2015
76. I. Lee, and et al. (-)-Epicatechin combined with 8 weeks of treadmill exercise is associated with increased angiogenic and mitochondrial signaling in mice Front. Pharmacol. 6 2015 43
77. I. Ramirez-Sanchez, and et al. Stimulatory effects of the flavanol (-)-epicatechin on cardiac angiogenesis: additive effects with exercise J. Cardiovasc. Pharmacol. 60 2012 429 438
78. I. Ramirez-Sanchez, and et al. (-)-Epicatechin activation of endothelial cell endothelial nitric oxide synthase, nitric oxide, and related signaling pathways Hypertension 55 2010 1398 1405
79. K.G. Yamazaki, and et al. Effects of (-)-epicatechin on myocardial infarct size and left ventricular remodeling after permanent coronary occlusion J. Am. Coll. Cardiol. 55 2010 2869 2876
80. K.G. Yamazaki, and et al. Short- and long-term effects of (-)-epicatechin on myocardial ischemia-reperfusion injury Am. J. Physiol. Heart Circ. Physiol. 295 2008 H761 H767
81. B. Buijsse, and et al. Chocolate consumption in relation to blood pressure and risk of cardiovascular disease in German adults Eur. Heart J. 31 2010 1616 1623
82. G.D. Wadley, and G.K. McConell Effect of nitric oxide synthase inhibition on mitochondrial biogenesis in rat skeletal muscle J. Appl. Physiol. 102 2007 314 320
83. G.D. Wadley, and et al. NOS isoform-specific regulation of basal but not exercise-induced mitochondrial biogenesis in mouse skeletal muscle J. Physiol. 585 2007 253 262
84. P.G. Lloyd, and et al. Angiogenic growth factor expression in rat skeletal muscle in rat skeletal muscle in response to exercise training Am. J. Physiol. Heart Circ. Physiol. 284 2003 H1668 H1678
85. J.I. Ottaviani, and et al. The stereochemical configuration of flavanols influences the level and metabolism of flavanols in humans and their biological activity in vivo Free Radic. Biol. Med. 50 2011 237 244
86. y mice Can. J. Physiol. Pharmacol. 90 2012 237 242
87. K.P. Goh, and et al. Effects of resveratrol in patients with type 2 diabetes mellitus on skeletal muscle SIRT1 expression and energy expenditure Int. J. Sport Nutr. Exerc. Metab. 24 2014 2 13
88. S. Timmers, and et al. The journey of resveratrol from yeast to human Aging (Albany NY) 4 2012 146 158
89. K. Higashida, and et al. Effects of resveratrol and SIRT1 on PGC-1α activity and mitochondrial biogenesis: a reevaluation PLoS Biol. 11 2013 e1001603
90. + metabolism and SIRT1 activity Nature 458 2009 1056 1060
91. C. Canto, and et al. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle Cell Metab. 11 2010 213 219
92. S.F. El-Khamisy, and et al. Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1 Nature 434 2005 108 113
93. Z. Gerhart-Hines, and et al. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1α EMBO J. 26 2007 1913 1923
94. I. Irrcher, and et al. AMP-activated protein kinase-regulated activation of the PGC-1α promoter in skeletal muscle cells PLoS ONE 3 2008 e3614
95. J. Lin, and et al. Metabolic control through the PGC-1 family of transcription coactivators Cell Metab. 1 2005 361 370
96. R.C. Scarpulla Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network Biochim. Biophys. Acta 1813 2011 1269 1278
97. S. Fukuda, and et al. Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor Flk-1 Cell Biochem. Biophys. 44 2006 43 49
98. B. Calamini, and et al. Pleiotropic mechanisms facilitated by resveratrol and its metabolites Biochem. J. 429 2010 273 282
99. N.L. Price, and et al. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function Cell Metab. 15 2012 675 690
100. R. Corder, and et al. Drinking your health? It's too early to say Nature 426 2003 119
101. T. Walle, and et al. High absorption but very low bioavailability of oral resveratrol in humans Drug Metab. Dispos. 32 2004 1377 1382
102. Y.S. Li, and et al. Molecular basis of the effects of shear stress on vascular endothelial cells J. Biomech. 38 2005 1949 1971
103. M.E. Lindholm, and et al. An integrative analysis reveals coordinated reprogramming of the epigenome and the transcriptome in human skeletal muscle after training Epigenetics 9 2014 1557 1569
104. N. Hart, and et al. Resveratrol enhances exercise training responses in rats selectively bred for high running performance Food Chem. Toxicol. 61 2013 53 59
105. H. Farghali, and et al. Resveratrol and related compounds as antioxidants with an allosteric mechanism of action in epigenetic drug targets Physiol. Res. 62 2013 1 13
106. D.R. Bolster, and et al. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling J. Biol. Chem. 277 2002 23977 23980
107. D. Meley, and et al. AMP-activated protein kinase and the regulation of autophagic proteolysis J. Biol. Chem. 281 2006 34870 34879
108. S. Miura, and et al. Overexpression of peroxisome proliferator-activated receptor γ co-activator-1α leads to muscle atrophy with depletion of ATP Am. J. Pathol. 169 2006 1129 1139
109. A. Porkrywka, and et al. Metabolic modulators of the exercise response: doping control analysis of an agonist of the peroxisome proliferator-activated receptor δ (GW501516) and 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) J. Physiol. Pharmacol. 65 2014 469 476
110. L.F. ten Brinke, and et al. Aerobic exercise increases hippocampal volume in older women with probable mild cognitive impairment: a 6-month randomised controlled trial Br. J. Sports Med. 49 2015 248 254
111. T. Liu-Ambrose, and et al. Resistance training and functional plasticity of the aging brain: a 12-month randomized controlled trial Neurobiol. Aging 33 2012 1690 1698